CLINICAL_TRIALS trial_result · 2019-01-23

Clinical Trial Update: A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. [Phase 1]

Phase 1 dose-escalation study of a Shigella sonnei vaccine in healthy adults has completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: GSK Vaccines Institute For Global Health S.r.l. | Conditions: Shigellosis | Phase 1 | Status: COMPLETED | Results posted: 2019-01-23